Impact of Immunosuppressive Drugs on Fibroblasts: An In Vitro Study

Area of Science:

• Pharmacology
• Cell Biology
• Immunology

Background:

• Drug-induced gingival overgrowth (DIGO) is a known side effect of immunosuppressive therapies.
• The direct cellular mechanisms underlying DIGO remain incompletely understood.
• Fibroblasts play a crucial role in tissue remodeling and are potential targets for DIGO.

Purpose of the Study:

• To investigate the direct impact of key immunosuppressive drugs (IsDs) on mouse fibroblast behavior.
• To compare the effects of cyclosporin A (CsA), tacrolimus (TaC), and sirolimus (SiR) on fibroblast cell characteristics.
• To assess the potential role of IsDs in drug-induced gingival overgrowth.

Main Methods:

• 3T3 mouse fibroblasts were cultured and exposed to varying concentrations of CsA, TaC, and SiR for different durations.
• Computer-assisted cell analysis was used to evaluate cell number, viability, and morphology.
• ELISA assays measured the expression of pro-collagen type I carboxy-terminal propeptide (PICP).

Main Results:

• Immunosuppressive drug effects on fibroblasts were time- and dose-dependent.
• CsA and TaC increased fibroblast cell numbers at specific concentrations (10–150 ng/mL).
• SiR significantly decreased fibroblast cell numbers (p < 0.01), while PICP and cell diameter were unaffected.

Conclusions:

• IsDs exhibit distinct time-dependent effects on fibroblast cell numbers.
• Fibroblast morphology and PICP expression are not directly altered by these IsDs.
• The mechanism of DIGO is likely multifactorial, not solely dependent on direct IsD effects on fibroblasts.